Promise of new vascular-disrupting agents balanced with cardiac toxicity: is it time for oncologists to get to know their cardiologists?
- PMID: 16574996
- DOI: 10.1200/JCO.2005.04.8801
Promise of new vascular-disrupting agents balanced with cardiac toxicity: is it time for oncologists to get to know their cardiologists?
Comment on
-
Phase I clinical evaluation of weekly administration of the novel vascular-targeting agent, ZD6126, in patients with solid tumors.J Clin Oncol. 2006 Apr 1;24(10):1491-8. doi: 10.1200/JCO.2005.02.7458. J Clin Oncol. 2006. PMID: 16574998 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources